Business & Regulation

The Global Vaccine Summit raised funds to improve international immunization programs.

Business insurance exists to help companies when unexpected events and damages occur – so you need to have the right policy in place.

EMA reviews lessons learned from nitrosamine impurities.

What makes pharma so good at rebranding?

Can the USA boost its manufacturing capacity for critical drugs?

Pfizer is supporting homelearners amid the COVID-19 pandemic.

From patient recruitment to distributing products, we ask how clinical trials can weather the COVID-19 pandemic.

Do pharma mergers and acquisitions improve R&D productivity and increase shareholder value?

How is the business of making medicine changing in light of the COVID-19 pandemic?

When developing countermeasures against COVID-19, resource-poor settings should not be forgotten.